(Q42927058)

11 November 2017

title

Risk of cardiovascular events and all-cause mortality in patients treated with thiazolidinediones in a managed-care population (English)

1 reference

11 November 2017

Risk of Cardiovascular Events and All-Cause Mortality in Patients Treated With Thiazolidinediones in a Managed-Care Population (English)

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

22 June 2024

1 reference

6

Rhonda L Bohn

1 reference

11 November 2017

Chun-Lan Chang

2

1 reference

11 November 2017

Debra A. Wertz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736441

22 June 2024

Chaitanya A. Sarawate

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736441

22 June 2024

Vincent J. Willey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736441

22 June 2024

Mark J. Cziraky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736441

22 June 2024

Rhonda L. Bohn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736441

22 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20736441

22 June 2024

publication date

24 August 2010

1 reference

Circulation: Cardiovascular Quality and Outcomes

11 November 2017

published in

1 reference

11 November 2017

volume

3

1 reference

11 November 2017

issue

5

1 reference

11 November 2017

page(s)

538-545

1 reference

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

11 November 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

22 June 2024

3

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment

22 June 2024

6

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

22 June 2024

Thiazolidinediones

7

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

22 June 2024

8

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

22 June 2024

9

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

22 June 2024

10

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

22 June 2024

11

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

The rosiglitazone story--lessons from an FDA Advisory Committee meeting

22 June 2024

14

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

22 June 2024

15

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy

22 June 2024

16

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study

22 June 2024

17

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project

22 June 2024

19

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

A primer and comparative review of major US mortality databases

22 June 2024

22

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

The accuracy of the National Death Index when personal identifiers other than Social Security number are used

22 June 2024

23

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

22 June 2024

25

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

22 June 2024

26

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations

22 June 2024

28

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis

22 June 2024

29

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Channeling bias in the interpretation of drug effects

22 June 2024

30

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

Addressing the issue of channeling bias in observational studies with propensity scores analysis

22 June 2024

31

1 reference

https://api.crossref.org/works/10.1161/CIRCOUTCOMES.109.911461

22 June 2024

Identifiers

1 reference

11 November 2017

1 reference